UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 29,809	$ 5,927
Interest, accounts receivable and other receivables, net	4,676	5,788
Assets held for sale, net (Note 4)	6,409	6,398
Finance receivables and related interest receivable held for sale (Note 4)	33,990	0
Other current assets	1,054	2,141
Total current assets	75,938	20,254
Finance receivables, net of allowance for credit losses of $8,785 and $11,249 as of March 31, 2025 and December 31, 2024, respectively	223,076	277,760
Collateral on foreign currency forward contract	2,750	2,750
Marketable investments	455	580
Deferred tax assets, net	22,219	23,484
Warrant assets	4,245	4,366
Property and equipment, net	28	48
Other non-current assets	2,553	2,993
Total assets	331,264	332,235
Current liabilities:
Accounts payable and accrued liabilities	2,045	2,810
Liabilities held for sale (Note 4)	1,325	1,255
Deferred income	3,349	1,500
Total current liabilities	6,719	5,565
Unsecured senior notes, net	31,567	31,412
Revolving credit facility	0	6,233
Other non-current liabilities	309	335
Total liabilities	38,595	43,545
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,222,522 and 12,213,599 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	12	12
Additional paid-in capital	4,419,431	4,419,991
Accumulated deficit	(4,126,774)	(4,131,313)
Total stockholders' equity	292,669	288,690
Total liabilities and stockholders' equity	$ 331,264	$ 332,235